Need Help?

Immunoglobulin Heavy-Chain locus in Multiple Sclerosis (n=4)

Peripheral-blood or monocyte DNA from two healthy donors and two individuals with multiple sclerosis were sequenced on a PromethION-2 Solo (P2 Solo) instrument using R10.4.1 flow-cells and the Ultra-Long DNA Sequencing Kit (SQK-ULK114). For each participant we provide FASTQ reads (on-target), and haplotype-resolved assemblies of the complete IGH locus (~1.3 Mb) in FASTA format.

Request Access

DUO:0000007
version: 2021-02-23

disease specific research

This data use permission indicates that use is allowed provided it is related to the specified disease.

ModifiersMONDO:0005301 – multiple sclerosis

DUO:0000021
version: 2021-02-23

ethics approval required

This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

DUO:0000028
version: 2021-02-23

institution specific restriction

This data use modifier indicates that use is limited to use within an approved institution.

Akershus University Hospital Data Access Policy for Immunoglobin Heavy-Chain locus Multiple Sclerosis datasets in FEGA Norway

Akershus University Hospital Data Access Policy for Immunoglobin Heavy-Chain locus Multiple Sclerosis datasets archived in Federated EGA Norway 1. Data Access Committee A Data Access Committee (DAC) is a body of one or more named individuals who are responsible for data release to external requesters based on consent and/or National Research Ethics terms. Each dataset submitted by Akershus University Hospital (Ahus) for archival and controlled access sharing in Federated EGA Norway, has a DAC appointed by Submitter Organisation to govern controlled access to the dataset according to this Data Access Policy. Multiple datasets may be affiliated to a single DAC. Submitter Organisation as an institution has the overall data controller responsibility, and will appoint a DAC based on proper internal procedures that ensures involvement of institutional functions such as Data Protection Officer, legal control, etc. 2. Data use conditions To advise any would-be requester on how the data can be used, Data Use Ontology codes (DUO) is associated to each dataset, providing the requester more insights into which terms for sharing and use of the data that applies, and that needs to be addressed as part of the communication with the DAC in a data access request. No access to an Ahus dataset deposited in FEGA Norway can be granted to a requester before all applicable conditions and requirements for the use and management of the data have been agreed upon in a signed Data Access Agreement. 3. Data Access Agreement The Data Access Agreement (DAA) includes requirements specific for both the dataset and the management of the data in the hands of the requester applying for access and is thus an individual DAA for each case of granted access to a dataset. As a rule, a DAA for an Ahus dataset will take the form of a Data Transfer Agreement, where the requester will commit to take on responsibilities and duties as a data controller. 4. Processing of requests for access The overall data access approval process at Ahus can be summarised as follows: 1. DAC for an Submitter Organisation dataset is contacted by a potential data requester 2. DAC continues communication with requester to understand the purpose of use, i.e. research setting the dataset is envisioned for by requester, to identify if data sharing is possible directly under current conditions for the dataset, or actions such as re-consenting is needed and desirable to accommodate the proposed research setting/data use. 3. A Data Access Agreement is jointly formulated and agreed upon, with the DAC following internal Submitter Organisation procedure to include the Data Protection Officer and Division for research support. 4. When a completed DAA has been signed between the parties, and archived at Ahus, the DAC will instruct the FEGA Norway node to release the data to the requester.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001042 Resequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF50000379692 fastq.gz 48.8 MB
Federated EGA
EGAF50000379693 fastq.gz 57.8 MB
Federated EGA
EGAF50000379694 fastq.gz 59.8 MB
Federated EGA
EGAF50000379695 fastq.gz 41.9 MB
Federated EGA
EGAF50000379696 fasta 3.1 MB
Federated EGA
EGAF50000379697 fasta 3.4 MB
Federated EGA
EGAF50000379698 fasta 3.0 MB
Federated EGA
EGAF50000379699 fasta 1.4 MB
Federated EGA
8 Files (219.3 MB)